| Literature DB >> 29518910 |
Diva Aliete Dos Santos Vieira1, Cristiane Hermes Sales2, Chester Luiz Galvão Cesar3, Dirce Maria Marchioni4, Regina Mara Fisberg5.
Abstract
Studies suggest that haem, non-haem iron and total iron intake may be related to non-communicable diseases, especially metabolic syndrome. This study was undertaken to investigate the association of haem, non-haem iron and total iron intake with metabolic syndrome and its components. A cross-sectional population-based survey was performed in 2008, enrolling 591 adults and elderly adults living in São Paulo, Brazil. Dietary intake was measured by two 24 h dietary recalls. Metabolic syndrome was defined as the presence of at least three of the following: hypertension, hyperglycaemia, dyslipidaemia and central obesity. The association between different types of dietary iron and metabolic syndrome was evaluated using multiple logistic regression. After adjustment for potential confounders, a higher haem iron intake was positively associated with metabolic syndrome and with elevated triglyceride levels. A higher total iron intake was positively associated with hyperglycaemia. Non-haem iron intake was positively associated with hyperglycaemia in the fourth quintile. In conclusion, this study suggests that the different types of dietary iron are associated with metabolic syndrome, elevated triglyceride levels and hyperglycaemia. In addition, it emphasises the importance of investigating the roles of dietary iron in health outcomes, since its consumption may have different impacts on health.Entities:
Keywords: epidemiologic surveys; food intake; iron intake; metabolic syndrome; nutritional assessment
Mesh:
Substances:
Year: 2018 PMID: 29518910 PMCID: PMC5872732 DOI: 10.3390/nu10030314
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Association between quintiles of iron intake (haem, non-haem and total) and metabolic syndrome in ISA-Capital. São Paulo, Brazil, 2008.
| Models | Quintiles of Iron Intake by Class, Odds Ratio (95% Confidence Interval) | |||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | ||
| Dietary intake (mg/day) | 0.56 | 0.74 | 0.91 | 1.12 | 1.40 | |
| Crude | 1.00 | 1.74 (0.92–3.29) | 1.35(0.69–2.64) | 0.88 (0.40–1.93) | 2.13 (1.01–4.52) | 0.375 |
| Model adjusted a | 1.00 | 1.98 (0.93–4.21) | 2.03 (0.94–4.39) | 1.17 (0.45–3.07) | 2.39 (1.10–5.21) | 0.228 |
| Dietary intake (mg/day) | 7.29 | 8.50 | 9.14 | 9.88 | 11.04 | |
| Crude | 1.00 | 0.98 (0.42–2.26) | 1.00 (0.48–2.08) | 0.89 (0.49–1.64) | 0.98 (0.47–1.64) | 0.856 |
| Model adjusted a | 1.00 | 1.02 (0.40–2.64) | 1.35 (0.53–3.44) | 0.87 (0.44–1.71) | 1.05 (0.44–2.48) | 0.945 |
| Dietary intake (mg/day) | 8.29 | 9.37 | 10.14 | 10.87 | 11.97 | |
| Crude | 1.00 | 0.94 (0.42–2.08) | 1.21 (0.61–2.39) | 0.57 (0.32–0.99) | 1.18 (0.55–2.41) | 0.947 |
| Model adjusted a | 1.00 | 0.83 (0.36–2.70) | 1.34 (0.63–2.84) | 0.52 (0.26–1.04) | 1.14 (0.54–2.40) | 0.891 |
a Adjusted for physical activity, gender, alcohol consumption, household per capita income, body mass index (BMI), high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat and vitamin C intakes. Haem and non-haem iron were mutually adjusted.
Association between quintiles of iron intake (haem, non-haem and total) and components of metabolic syndrome in ISA-Capital. São Paulo, Brazil, 2008.
| Models | Quintiles of Iron Intake by Class, Odds Ratio (95% Confidence Interval) | |||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | ||
| Hypertension or Hypertensive Drug Therapy for Hypertension | ||||||
| Crude | 1.00 | 1.63 (0.90–2.96) | 1.27 (0.60–2.71) | 1.55 (0.74–3.23) | 1.51 (0.78–2.93) | 0.345 |
| Model adjusted a | 1.00 | 1.72 (0.77–3.82) | 1.39 (0.60–3.21) | 2.14 (0.97–4.72) | 1.59 (0.73–3.49) | 0.183 |
| Crude | 1.00 | 0.96 (0.51–1.77) | 0.78 (0.39–1.57) | 0.99 (0.51–1.93) | 0.54 (0.24–1.26) | 0.226 |
| Model adjusted b | 1.00 | 0.73 (0.33–1.63) | 0.65 (0.28–1.51) | 0.78 (0.34–1.81) | 0.40 (0.15–1.10) | 0.135 |
| Crude | 1.00 | 1.21 (0.71–2.05) | 1.14 (0.55–2.39) | 0.66 (0.31–1.39) | 0.79 (0.37–1.68) | 0.279 |
| Model adjusted c | 1.00 | 0.85 (0.43–1.66) | 0.93 (0.40–2.16) | 0.51 (0.21–1.29) | 0.57 (0.24–1.39) | 0.154 |
| Hyperglycaemia or Therapy for Elevated Glucose | ||||||
| Crude | 1.00 | 1.49 (0.69–3.22) | 1.94 (0.76–4.99) | 0.61 (0.23–1.59) | 1.84 (0.75–4.54) | 0.660 |
| Model adjusted a | 1.00 | 1.56 (0.56–4.34) | 2.53 (0.98–6.57) | 0.66 (0.18–2.33) | 1.65 (0.63–4.33) | 0.746 |
| Crude | 1.00 | 2.87 (0.96–8.57) | 1.78 (0.56–5.63) | 2.86 (1.19–6.89) | 2.87 (0.99–8.36) | 0.070 |
| Model adjusted b | 1.00 | 3.21 (1.11–9.27) | 1.93 (0.60–6.26) | 2.92 (1.10–7.72) | 2.56 (0.83–7.93) | 0.183 |
| Crude | 1.00 | 3.64 (1.27–10.44) | 1.89 (0.64–5.57) | 1.86 (0.76–4.50) | 4.59 (1.71–12.29) | 0.036 |
| Model adjusted c | 1.00 | 3.50 (1.28–9.61) | 1.75 (0.56–5.43) | 1.49 (0.54–4.11) | 3.98 (1.21–13.12) | 0.131 |
| Elevated Triglycerides or Therapy for Elevated Triglycerides | ||||||
| Crude | 1.00 | 2.04 (0.92–4.52) | 1.46 (0.81–2.63) | 1.42 (0.70–2.90) | 2.73 (1.25–5.96) | 0.060 |
| Model adjusted a | 1.00 | 2.75 (1.13–6.73) | 1.87 (0.95–3.66) | 1.64 (0.77–3.50) | 2.51 (1.06–5.91) | 0.139 |
| Crude | 1.00 | 1.47 (0.77–2.81) | 1.54 (0.79–3.01) | 1.17 (0.63–2.15) | 1.16 (0.52–2.58) | 0.852 |
| Model adjusted b | 1.00 | 1.51 (0.71–3.18) | 1.78 (0.85–3.72) | 0.94 (0.44–2.03) | 0.88 (0.31–2.47) | 0.554 |
| Crude | 1.00 | 1.11 (0.51–2.43) | 1.70 (0.88–3.27) | 1.03 (0.54–2.00) | 1.19 (0.55–2.56) | 0.700 |
| Model adjusted c | 1.00 | 1.22 (0.54–2.76) | 1.95 (1.00–3.86) | 0.97 (0.43–2.18) | 0.99 (0.43–2.28) | 0.821 |
| Reduced HDL-c (high-density lipoprotein cholesterol) | ||||||
| Crude | 1.00 | 1.27 (0.64–2.52) | 0.88 (0.42–1.85) | 0.81 (0.33–1.95) | 1.70 (0.82–3.50) | 0.506 |
| Model adjusted a | 1.00 | 1.22 (0.56–2.66) | 1.15 (0.46–2.87) | 1.06 (0.41–2.78) | 2.09 (0.88–4.94) | 0.189 |
| Crude | 1.00 | 0.71 (0.30–1.66) | 0.73 (0.38–1.39) | 0.89 (0.42–1.89) | 1.26 (0.65–2.47) | 0.477 |
| Model adjusted b | 1.00 | 0.68 (0.30–1.54) | 0.67 (0.37–1.21) | 0.87 (0.36–2.2) | 1.16 (0.53–2.55) | 0.641 |
| Crude | 1.00 | 0.55 (0.25–1.19) | 0.68 (0.37–1.27) | 0.65 (0.32–1.33) | 1.21 (0.61–2.41) | 0.604 |
| Model adjusted c | 1.00 | 0.50 (0.24–1.06) | 0.58 (0.31–1.09) | 0.57 (0.25–1.32) | 1.16 (0.51–2.63) | 0.746 |
| Increased Waist Circumference | ||||||
| Crude | 1.00 | 1.72 (0.62–4.79) | 0.99 (0.50–1.98) | 0.85 (0.35–2.07) | 1.14 (0.50–2.61) | 0.650 |
| Model adjusted d | 1.00 | 1.61 (0.56–4.62) | 1.18 (0.55–2.53) | 0.95 (0.36–2.48) | 0.99 (0.39–2.54) | 0.644 |
| Crude | 1.00 | 1.51 (0.67–3.41) | 1.04 (0.56–1.93) | 1.39 (0.79–2.45) | 1.29 (0.56–2.97) | 0.555 |
| Model adjusted e | 1.00 | 1.38 (0.48–3.93) | 1.03 (0.43–2.49) | 1.39 (0.68–2.83) | 1.23 (0.47–3.20) | 0.659 |
| Crude | 1.00 | 1.42 (0.62–3.24) | 0.94 (0.49–1.78) | 1.31 (0.71–2.40) | 1.42 (0.63–3.20) | 0.426 |
| Model adjusted f | 1.00 | 0.97 (0.38–2.49) | 0.72 (0.30–1.73) | 1.25 (0.58–2.71) | 1.00 (0.39–2.56) | 0.837 |
a Adjusted for physical activity, gender, alcohol consumption, household per capita income, BMI, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, vitamin C and nonhaem iron intakes. b Adjusted for physical activity, gender, alcohol consumption, household per capita income, BMI, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, fibre, vitamin C and haem iron intakes. c Adjusted for physical activity, gender, alcohol consumption, household per capita income, BMI, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, fibre, vitamin C intakes. d Adjusted for physical activity, gender, alcohol consumption, household per capita income, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, vitamin C and non-haem iron intakes. e Adjusted for physical activity, gender, alcohol consumption, household per capita income, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, fibre, vitamin C and haem iron intakes. f Adjusted for physical activity, gender, alcohol consumption, household per capita income, high-sensitivity C-reactive protein, age, smoking status, race, total energy intake, misreporting, saturated fat, fibre and vitamin C intakes.